The relationship between estimated sodium and potassium excretion and subsequent renal outcomes

Kidney International

Volumn 86, Issue 6, 2014, Pages 1205-1212

  Smyth, Andrew ^a,b   Dunkler, Daniela ^b,c   Gao, Peggy ^b   Teo, Koon K ^b   Yusuf, Salim ^b   O'Donnell, Martin J ^a,b   Mann, Johannes F E ^b,c   Clase, Catherine M ^d  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; POTASSIUM; SODIUM;

AGED; ALBUMINURIA; ARTICLE; ATTRIBUTABLE RISK; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DIALYSIS; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERKALEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POTASSIUM EXCRETION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; SODIUM EXCRETION; SODIUM URINE LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; URINE;

AGED; ALBUMINURIA; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERKALEMIA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POTASSIUM; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SODIUM;

EID: 84926189066     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.214     Document Type: Article

References (31)

1. KDIGO 2012. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150.
2. World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Cardiovascular Risk. World Health Organization: Geneva, 2007.
3. Thomas MC, Moran J, Forsblom C et al. The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care 2011; 34: 861-866.
4. O'Donnell MJ, Yusuf S, Mente A et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA 2011; 306: 2229-2238.
5. K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Guideline 6. Dietary and other therapeutic lifestyle changes in adults. National Kidney Foundation Kidney Disease Outcomes Quality Initiative.
6. Yusuf S, Teo KK, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559.
7. Yusuf S, Teo K, Anderson C et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: A randomised controlled trial. Lancet 2008; 372: 1174-1183.
8. Aburto NJ, Hanson S, Gutierrez H et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ 2013; 346: f1378.
9. Vegter S, Perna A, Postma MJ et al. Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol 2012; 23: 165.
10. Amaha M, Ohashi Y, Sakai K et al. Salt intake and the progression of renal failure in patients with chronic kidney disease. Nihon Jinzo Gakkai Shi 2010; 52: 952-958.
11. Cianciaruso B, Bellizzi V, Minutolo R et al. Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 1998; 24: 296-301.
12. Smyth A, O'Donnell MJ, Yusuf S et al. Sodium intake and renal outcomes: A systematic review. Am J Hypertens (e-pub ahead of print 7 February 2014).
13. Sharma S, McFann K, Chonchol M et al. Association between dietary sodium and potassium intake with chronic kidney disease in US adults: A cross-sectional study. Am J Nephrol 2013; 37: 526-533.
14. Buter H, Hemmelder MH, Navis G et al. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide. Nephrol Dial Transplant 1998; 13: 1682-1685.
15. Patki PS, Singh J, Gokhale SV et al. Efficacy of potassium and magnesium in essential hypertension: A double-blind, placebo controlled, crossover study. BMJ 1990; 301: 521-523.
16. Smith SJ, Markandu ND, Sagnella GA et al. Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction? Br Med J (Clin Res Ed) 1985; 290: 110-113.
17. Bulpitt CJ, Ferrier G, Lewis PJ et al. Potassium supplementation fails to lower blood pressure in hypertensive patients receiving a potassium losing diuretic. Ann Clin Res 1985; 17: 126-130.
18. Dunkler D, Dehghan M, Teo KK et al. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med 2013; 173: 1682-1692.
19. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97.
20. Young DB, Lin H, McCabe RD. Potassium's cardiovascular protective mechanisms.. Am J Physiol 1995; 268(4 Pt 2): R825-R837.
21. Ardiles L, Cardenas A, Burgos ME et al. Antihypertensive and renoprotective effect of the kinin pathway activated by potassium in a model of salt sensitivity following overload proteinuria. Am J Physiol Renal Physiol 2013; 304: F1399-F1410.
22. Tobe SW, Clase CM, Gao P et al. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies. Circulation 2011; 123: 1098-1107.
23. Korgaonkar S, Tilea A, Gillespie BW et al. Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study. Clin J Am Soc Nephrol 2010; 5: 762-769.
24. Luft FC, Fineberg NS, Sloan RS. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension 1982; 4: 805-808.
25. Imai E, Yasuda Y, Horio M et al. Validation of the equations for estimating daily sodium excretion from spot urine in patients with chronic kidney disease. Clin Exp Nephrol 2011; 15: 861-867.
26. Kawasaki T, Itoh K, Uezono K et al. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol 1993; 20: 7-14.
27. Koh K-H, Tan C, Hii L. Study of low salt diet in hypertensive patients with chronic kidney disease (CKD). Int J Cardiol 2011; 152: S104.
28. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
29. Barzilay JI, Gao P, O'Donnell M et al. Albuminuria and decline in cognitive function: the ONTARGET/TRANSCEND studies. Arch Int Med 2011; 171: 142-150.
30. Kawamura M, Kusano Y, Takahashi T et al. Effectiveness of a spot urine method in evaluating daily salt intake in hypertensive patients taking oral antihypertensive drugs. Hypertens Res 2006; 29: 397-402.
31. Teo K, Chow CK, Vaz M et al. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 2009; 158: 1-7 e1.